香港电讯(06823.HK)夥富卫及医思医疗(02138.HK)为400基层家庭提供免费遥距医疗谘询服务
香港电讯(06823.HK)、富卫及香港医思医疗集团(02138.HK) 宣布为香港明爱青少年及社区服务的400户基层家庭提供免费DrGo遥距医疗谘询服务,包括由医思医疗提供的遥距视像会诊、普通科医生可能开出最多三日标准处方药物及一次性送递服务。
透过香港电讯的一站式遥距医疗服务平台DrGo,可以将用户与香港注册医生联系起来,而医生透过视像会诊提供医疗谘询服务。处方药物一般最快可於4小时内送递至用户的指定地址,用户可安坐家中或工作场所与医生对话,而毋须亲身前往医院或诊所排队。(el/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.